Evaluation of the Long-Term Benefits and Cost-Effectiveness of Colorectal Cancer Screening for Populations with Excess Weight - China, 2023.

IF 2.9 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

中国疾病预防控制中心周报 Pub Date : 2025-08-29 DOI:10.46234/ccdcw2025.190

Jiaxin Xie, Xuesi Dong, Chenran Wang, Yadi Zheng, Zilin Luo, Xiaolu Chen, Zeming Guo, Xiaoyue Shi, Wei Cao, Fei Wang, Ni Li

{"title":"Evaluation of the Long-Term Benefits and Cost-Effectiveness of Colorectal Cancer Screening for Populations with Excess Weight - China, 2023.","authors":"Jiaxin Xie, Xuesi Dong, Chenran Wang, Yadi Zheng, Zilin Luo, Xiaolu Chen, Zeming Guo, Xiaoyue Shi, Wei Cao, Fei Wang, Ni Li","doi":"10.46234/ccdcw2025.190","DOIUrl":null,"url":null,"abstract":"What is already known on this topic?: China has the world's largest population of individuals who are overweight or obese, contributing to the growing burden of colorectal cancer (CRC). Screening is an effective strategy for reducing CRC mortality and incidence.What is added by this report?: Using a simulation model, we found that CRC screening reduces incidence and mortality across all body mass index groups (normal, overweight, and obese) in China, with greater quality-adjusted life-year gains and 6%-14% higher colonoscopy efficiency in individuals who are overweight or obese. Screening proved to be more cost-effective for these groups, despite high lifetime healthcare expenditures.What are the implications for public health practice?: CRC screening in China can prioritize populations with excess weight and incorporate weight management to improve health outcomes and control long-term healthcare costs.","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"7 35","pages":"1132-1137"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421419/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2025.190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

What is already known on this topic?: China has the world's largest population of individuals who are overweight or obese, contributing to the growing burden of colorectal cancer (CRC). Screening is an effective strategy for reducing CRC mortality and incidence.

What is added by this report?: Using a simulation model, we found that CRC screening reduces incidence and mortality across all body mass index groups (normal, overweight, and obese) in China, with greater quality-adjusted life-year gains and 6%-14% higher colonoscopy efficiency in individuals who are overweight or obese. Screening proved to be more cost-effective for these groups, despite high lifetime healthcare expenditures.

What are the implications for public health practice?: CRC screening in China can prioritize populations with excess weight and incorporate weight management to improve health outcomes and control long-term healthcare costs.

查看原文本刊更多论文

对超重人群进行结直肠癌筛查的长期收益和成本效益评估——中国，2023。

关于这个话题我们已经知道了什么？中国是世界上超重或肥胖人口最多的国家，这是导致结直肠癌（CRC）负担增加的原因之一。筛查是降低结直肠癌死亡率和发病率的有效策略。这份报告增加了什么内容？使用模拟模型，我们发现CRC筛查降低了中国所有体重指数组（正常、超重和肥胖）的发病率和死亡率，超重或肥胖个体的质量调整生命年收益更大，结肠镜检查效率提高6%-14%。事实证明，尽管终生医疗保健支出较高，但筛查对这些群体更具成本效益。这对公共卫生实践有什么影响？在中国进行结直肠癌筛查可以优先考虑超重人群，并结合体重管理来改善健康结果和控制长期医疗保健费用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国疾病预防控制中心周报

CiteScore

5.90

自引率

0.00%

发文量